Chemist at work in laboratory.
Our Work

Latham Advises Senior and Private PIK Lenders on Axplora’s €530 Million Cross-Border Refinancing

July 25, 2025
London-led finance team represents lenders in the refinancing of a leading manufacturer of active pharmaceutical ingredient solutions.

Latham & Watkins has advised the senior lender group and the private PIK lenders on Axplora’s successful €530 million cross-border senior and Holdco PIK refinancing. Axplora is a leading manufacturer of active pharmaceutical ingredient (API) solutions headquartered in Germany, and a portfolio company of Bridgepoint, one of the world’s leading quoted private asset growth investors.

The transaction reinforces the Axplora Group’s financial foundation as it continues to strengthen its market-leading presence and global operations in the pharmaceutical sector.

The Latham banking and private credit team was led by London finance partners Fergus Wheeler and Dan Maze, with associates Medha Vikram and Hafsa Raza.

 

Endnotes